{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:17:35Z","timestamp":1794741455614,"version":"4.9.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["24077"],"award-info":[{"award-number":["24077"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["24077"],"award-info":[{"award-number":["24077"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["24077"],"award-info":[{"award-number":["24077"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004923","name":"AFM-T\u00e9l\u00e9thon","doi-asserted-by":"publisher","award":["20568"],"award-info":[{"award-number":["20568"]}],"id":[{"id":"10.13039\/501100004923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["2017FJSM9S"],"award-info":[{"award-number":["2017FJSM9S"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["2020ELYA32004"],"award-info":[{"award-number":["2020ELYA32004"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["2017FJSM9S"],"award-info":[{"award-number":["2017FJSM9S"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["2020ELYA32004"],"award-info":[{"award-number":["2020ELYA32004"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Duchenne muscular dystrophy (DMD) is a devastating genetic disorder, whose management is still a major challenge, despite progress in genetic and pharmacological disease-modifying treatments have been made. Mitochondrial dysfunctions contribute to DMD, however, there are no effective mitochondrial therapies for DMD. SIRT1 is a NAD\n                    <jats:sup>+<\/jats:sup>\n                    -dependent deacetylase that controls several key processes and whose impairment is involved in determining mitochondrial dysfunction in DMD. In addition to well-known resveratrol, other potent selective activators of SIRT1 exist, with better pharmacokinetics properties and a safer profile. Among these, SRT2104 is the most promising and advanced in clinical studies. Here we unveil the beneficial effects of SRT2104 in flies, mice, and patient-derived myoblasts as different models of DMD, demonstrating an anti-inflammatory, anti-fibrotic, and pro-regenerative action of the drug. We elucidate, by molecular dynamics simulations, that a conformational selection mechanism is responsible for the activation of SIRT1. Further, the impact of SRT2104 in reshaping muscle proteome and acetylome profiles has been investigated, highlighting effects that mimic those induced by exercise. Overall, our data suggest SRT2104 as a possible therapeutic candidate to successfully counteract DMD progression.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-07595-z","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T09:35:37Z","timestamp":1744018537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The SIRT1 activator SRT2104 exerts exercise mimetic effects and promotes Duchenne muscular dystrophy recovery"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9083-4935","authenticated-orcid":false,"given":"Matteo","family":"Giovarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Zecchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4393-7691","authenticated-orcid":false,"given":"Silvia Rosanna","family":"Casati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8023-593X","authenticated-orcid":false,"given":"Laura","family":"Lociuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8611-0523","authenticated-orcid":false,"given":"Oriola","family":"Gjana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Mollica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pisanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harcel Djaya","family":"Mbissam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Cappellari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Arcari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0337-5425","authenticated-orcid":false,"given":"Anne","family":"Bigot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuditta","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1210-6836","authenticated-orcid":false,"given":"Elisabetta","family":"Catalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Del Quondam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0566-2391","authenticated-orcid":false,"given":"Annapaola","family":"Andolfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6343-9614","authenticated-orcid":false,"given":"Clarissa","family":"Braccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Banfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Mocciaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7333-8270","authenticated-orcid":false,"given":"Emilio","family":"Clementi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2727-9449","authenticated-orcid":false,"given":"Davide","family":"Cervia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6680-4536","authenticated-orcid":false,"given":"Cristiana","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0365-7414","authenticated-orcid":false,"given":"Clara","family":"De Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"7595_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","volume":"1","author":"AE Emery","year":"1991","unstructured":"Emery AE. Population frequencies of inherited neuromuscular diseases-a world survey. Neuromuscul Disord. 1991;1:19\u201329.","journal-title":"Neuromuscul Disord"},{"key":"7595_CR2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","volume":"24","author":"JK Mah","year":"2014","unstructured":"Mah JK, Korngut L, Dykeman J, Day L, Pringsheim T, Jette N. A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy. Neuromuscular Disord. 2014;24:482\u201391.","journal-title":"Neuromuscular Disord"},{"key":"7595_CR3","doi-asserted-by":"publisher","first-page":"1183101","DOI":"10.3389\/fphys.2023.1183101","volume":"14","author":"A Bez Batti Angulski","year":"2023","unstructured":"Bez Batti Angulski A, Hosny N, Cohen H, Martin AA, Hahn D, Bauer J, et al. Duchenne muscular dystrophy: disease mechanism and therapeutic strategies. Front Physiol. 2023;14:1183101.","journal-title":"Front Physiol"},{"key":"7595_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13023-021-01758-9","volume":"16","author":"S Kourakis","year":"2021","unstructured":"Kourakis S, Timpani CA, Campelj DG, Hafner P, Gueven N, Fischer D, et al. Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: can we do better? Orphanet J Rare Dis. 2021;16:117.","journal-title":"Orphanet J Rare Dis"},{"key":"7595_CR5","doi-asserted-by":"crossref","unstructured":"Heydemann A, Siemionow M. A brief review of Duchenne muscular dystrophy treatment options, with an emphasis on two novel strategies. Biomedicines. 2023;11:830.","DOI":"10.3390\/biomedicines11030830"},{"key":"7595_CR6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1152\/physiolgenomics.00134.2017","volume":"50","author":"AA Fiorillo","year":"2018","unstructured":"Fiorillo AA, Tully CB, Damsker JM, Nagaraju K, Hoffman EP, Heier CR. Muscle miRNAome shows suppression of chronic inflammatory miRNAs with both prednisone and vamorolone. Physiol Genom. 2018;50:735\u201345.","journal-title":"Physiol Genom"},{"key":"7595_CR7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/cdd.2016.127","volume":"24","author":"MC Vila","year":"2017","unstructured":"Vila MC, Rayavarapu S, Hogarth MW, Van der Meulen JH, Horn A, Defour A, et al. Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophy. Cell Death Differ. 2017;24:330\u201342.","journal-title":"Cell Death Differ"},{"key":"7595_CR8","doi-asserted-by":"publisher","first-page":"361ra139","DOI":"10.1126\/scitranslmed.aaf5504","volume":"8","author":"D Ryu","year":"2016","unstructured":"Ryu D, Zhang H, Ropelle ER, Sorrentino V, Mazala DA, Mouchiroud L, et al. NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation. Science Transl Med. 2016;8:361ra139.","journal-title":"Science Transl Med"},{"key":"7595_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/hmg\/dds415","volume":"22","author":"JM Percival","year":"2013","unstructured":"Percival JM, Siegel MP, Knowels G, Marcinek DJ. Defects in mitochondrial localization and ATP synthesis in the mdx mouse model of Duchenne muscular dystrophy are not alleviated by PDE5 inhibition. Hum Mol Genet. 2013;22:153\u201367.","journal-title":"Hum Mol Genet"},{"key":"7595_CR10","doi-asserted-by":"publisher","first-page":"105751","DOI":"10.1016\/j.phrs.2021.105751","volume":"170","author":"M Giovarelli","year":"2021","unstructured":"Giovarelli M, Zecchini S, Catarinella G, Moscheni C, Sartori P, Barbieri C, et al. Givinostat as metabolic enhancer reverting mitochondrial biogenesis deficit in Duchenne Muscular Dystrophy. Pharmacol Res. 2021;170:105751.","journal-title":"Pharmacol Res"},{"key":"7595_CR11","first-page":"368276","volume":"2011","author":"R Rajendran","year":"2011","unstructured":"Rajendran R, Garva R, Krstic-Demonacos M, Demonacos C. Sirtuins: molecular traffic lights in the crossroad of oxidative stress, chromatin remodeling, and transcription. J Biomed Biotechnol. 2011;2011:368276.","journal-title":"J Biomed Biotechnol"},{"key":"7595_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20070140","volume":"404","author":"S Michan","year":"2007","unstructured":"Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J. 2007;404:1\u201313.","journal-title":"Biochem J"},{"key":"7595_CR13","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1101\/gad.265462.115","volume":"29","author":"D Cao","year":"2015","unstructured":"Cao D, Wang M, Qiu X, Liu D, Jiang H, Yang N, et al. Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol. Genes Dev. 2015;29:1316\u201325.","journal-title":"Genes Dev"},{"key":"7595_CR14","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1016\/j.bbapap.2009.10.022","volume":"1804","author":"T Zhang","year":"2010","unstructured":"Zhang T, Kraus WL. SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions. Biochim Biophys Acta. 2010;1804:1666\u201375.","journal-title":"Biochim Biophys Acta"},{"key":"7595_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cmet.2010.02.006","volume":"11","author":"C Canto","year":"2010","unstructured":"Canto C, Jiang LQ, Deshmukh AS, Mataki C, Coste A, Lagouge M, et al. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 2010;11:213\u20139.","journal-title":"Cell Metab"},{"key":"7595_CR16","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/sj.emboj.7601633","volume":"26","author":"Z Gerhart-Hines","year":"2007","unstructured":"Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, Mostoslavsky R, et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1\/PGC-1alpha. EMBO J. 2007;26:1913\u201323.","journal-title":"EMBO J"},{"key":"7595_CR17","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s10753-020-01242-9","volume":"43","author":"V Singh","year":"2020","unstructured":"Singh V, Ubaid S. Role of Silent Information Regulator 1 (SIRT1) in regulating oxidative stress and inflammation. Inflammation. 2020;43:1589\u201398.","journal-title":"Inflammation"},{"key":"7595_CR18","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1126\/science.1231097","volume":"339","author":"BP Hubbard","year":"2013","unstructured":"Hubbard BP, Gomes AP, Dai H, Li J, Case AW, Considine T, et al. Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science. 2013;339:1216\u20139.","journal-title":"Science"},{"key":"7595_CR19","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nature06261","volume":"450","author":"JC Milne","year":"2007","unstructured":"Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 2007;450:712\u20136.","journal-title":"Nature"},{"key":"7595_CR20","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1124\/jpet.111.183210","volume":"338","author":"YS Hori","year":"2011","unstructured":"Hori YS, Kuno A, Hosoda R, Tanno M, Miura T, Shimamoto K, et al. Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. J Pharm Exp Ther. 2011;338:784\u201394.","journal-title":"J Pharm Exp Ther"},{"key":"7595_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/nyas.12812","volume":"1348","author":"A Kuno","year":"2015","unstructured":"Kuno A, Tanno M, Horio Y. The effects of resveratrol and SIRT1 activation on dystrophic cardiomyopathy. Ann N. Y Acad Sci. 2015;1348:46\u201354.","journal-title":"Ann N. Y Acad Sci"},{"key":"7595_CR22","doi-asserted-by":"publisher","first-page":"9179270","DOI":"10.1155\/2018\/9179270","volume":"2018","author":"R Sebori","year":"2018","unstructured":"Sebori R, Kuno A, Hosoda R, Hayashi T, Horio Y. Resveratrol decreases oxidative stress by restoring mitophagy and improves the pathophysiology of dystrophin-deficient mdx mice. Oxid Med Cell Longev. 2018;2018:9179270.","journal-title":"Oxid Med Cell Longev"},{"key":"7595_CR23","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1124\/dmd.104.000885","volume":"32","author":"T Walle","year":"2004","unstructured":"Walle T, Hsieh F, DeLegge MH, Oatis JE Jr., Walle UK. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 2004;32:1377\u201382.","journal-title":"Drug Metab Dispos"},{"key":"7595_CR24","doi-asserted-by":"publisher","first-page":"837042","DOI":"10.1155\/2015\/837042","volume":"2015","author":"J Gambini","year":"2015","unstructured":"Gambini J, Ingles M, Olaso G, Lopez-Grueso R, Bonet-Costa V, Gimeno-Mallench L, et al. Properties of resveratrol: in vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans. Oxid Med Cell Longev. 2015;2015:837042.","journal-title":"Oxid Med Cell Longev"},{"key":"7595_CR25","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1124\/dmd.106.013987","volume":"35","author":"D Ung","year":"2007","unstructured":"Ung D, Nagar S. Variable sulfation of dietary polyphenols by recombinant human sulfotransferase (SULT) 1A1 genetic variants and SULT1E1. Drug Metab Dispos. 2007;35:740\u20136.","journal-title":"Drug Metab Dispos"},{"key":"7595_CR26","doi-asserted-by":"publisher","first-page":"155932581772373","DOI":"10.1177\/1559325817723731","volume":"15","author":"H Mehboob","year":"2017","unstructured":"Mehboob H, Tahir IM, Iqbal T, Saleem S, Perveen S, Farooqi A. Effect of UDP-Glucuronosyltransferase (UGT) 1A Polymorphism (rs8330 and rs10929303) on Glucuronidation Status of Acetaminophen. Dose-response. 2017;15:1559325817723731.","journal-title":"Dose-response"},{"key":"7595_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-55923-8","volume":"14","author":"N Chang","year":"2024","unstructured":"Chang N, Li J, Lin S, Zhang J, Zeng W, Ma G, et al. Emerging roles of SIRT1 activator, SRT2104, in disease treatment. Sci Rep. 2024;14. 5521.","journal-title":"Sci Rep"},{"key":"7595_CR28","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-2125.2012.04340.x","volume":"75","author":"E Hoffmann","year":"2013","unstructured":"Hoffmann E, Wald J, Lavu S, Roberts J, Beaumont C, Haddad J, et al. Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man. Br J Clin Pharmacol. 2013;75:186\u201396.","journal-title":"Br J Clin Pharmacol"},{"key":"7595_CR29","doi-asserted-by":"crossref","unstructured":"Liu H, Zhang Y, Zhang H, Xu S, Zhao H, Liu X. Abeta-INDUCED DAMAGE MEMory in hCMEC\/D3 cells mediated by Sirtuin-1. Int J Mol Sci. 2020;21:8226.","DOI":"10.3390\/ijms21218226"},{"key":"7595_CR30","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/acn3.135","volume":"1","author":"M Jiang","year":"2014","unstructured":"Jiang M, Zheng J, Peng Q, Hou Z, Zhang J, Mori S, et al. Sirtuin 1 activator SRT2104 protects Huntington\u2019s disease mice. Annals Clin Transl Neurol. 2014;1:1047\u201352.","journal-title":"Annals Clin Transl Neurol"},{"key":"7595_CR31","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.arcmed.2011.07.005","volume":"42","author":"J Yang","year":"2011","unstructured":"Yang J, Wang N, Zhu Y, Feng P. Roles of SIRT1 in high glucose-induced endothelial impairment: association with diabetic atherosclerosis. Arch Med Res. 2011;42:354\u201360.","journal-title":"Arch Med Res"},{"key":"7595_CR32","doi-asserted-by":"publisher","first-page":"e0142081","DOI":"10.1371\/journal.pone.0142081","volume":"10","author":"JG Krueger","year":"2015","unstructured":"Krueger JG, Suarez-Farinas M, Cueto I, Khacherian A, Matheson R, Parish LC, et al. A Randomized, Placebo-Controlled Study of SRT2104, a SIRT1 activator, in patients with moderate to severe Psoriasis. PLoS ONE. 2015;10:e0142081.","journal-title":"PLoS ONE"},{"key":"7595_CR33","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/MIB.0000000000000597","volume":"22","author":"BE Sands","year":"2016","unstructured":"Sands BE, Joshi S, Haddad J, Freudenberg JM, Oommen DE, Hoffmann E, et al. Assessing colonic exposure, safety, and clinical activity of SRT2104, a novel oral SIRT1 activator, in patients with mild to moderate ulcerative colitis. Inflamm Bowel Dis. 2016;22:607\u201314.","journal-title":"Inflamm Bowel Dis"},{"key":"7595_CR34","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.biopsych.2016.01.009","volume":"80","author":"N Abe-Higuchi","year":"2016","unstructured":"Abe-Higuchi N, Uchida S, Yamagata H, Higuchi F, Hobara T, Hara K, et al. Hippocampal Sirtuin 1 signaling mediates depression-like behavior. Biol Psychiatry. 2016;80:815\u201326.","journal-title":"Biol Psychiatry"},{"key":"7595_CR35","doi-asserted-by":"crossref","unstructured":"Wesolowski LT, Simons JL, Semanchik PL, Othman MA, Kim JH, Lawler JM, et al. The Impact of SRT2104 on skeletal muscle mitochondrial function, redox biology, and loss of muscle mass in hindlimb unloaded rats. Int J Mol Sci. 2023;24:11135.","DOI":"10.3390\/ijms241311135"},{"key":"7595_CR36","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/acel.12220","volume":"13","author":"EM Mercken","year":"2014","unstructured":"Mercken EM, Mitchell SJ, Martin-Montalvo A, Minor RK, Almeida M, Gomes AP, et al. SRT2104 extends survival of male mice on a standard diet and preserves bone and muscle mass. Aging cell. 2014;13:787\u201396.","journal-title":"Aging cell"},{"key":"7595_CR37","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1097\/CCM.0000000000000949","volume":"43","author":"AJ van der Meer","year":"2015","unstructured":"van der Meer AJ, Scicluna BP, Moerland PD, Lin J, Jacobson EW, Vlasuk GP, et al. The selective Sirtuin 1 Activator SRT2104 reduces endotoxin-induced cytokine release and coagulation activation in humans. Crit Care Med. 2015;43:e199\u2013202.","journal-title":"Crit Care Med"},{"key":"7595_CR38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13023-015-0311-0","volume":"10","author":"D Miglietta","year":"2015","unstructured":"Miglietta D, De Palma C, Sciorati C, Vergani B, Pisa V, Villa A, et al. Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy. Orphanet J Rare Dis. 2015;10:101.","journal-title":"Orphanet J Rare Dis"},{"key":"7595_CR39","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s00018-020-03598-5","volume":"78","author":"E Catalani","year":"2021","unstructured":"Catalani E, Bongiorni S, Taddei AR, Mezzetti M, Silvestri F, Coazzoli M, et al. Defects of full-length dystrophin trigger retinal neuron damage and synapse alterations by disrupting functional autophagy. Cell Mol Life Sci. 2021;78:1615\u201336.","journal-title":"Cell Mol Life Sci"},{"key":"7595_CR40","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/15548627.2018.1507439","volume":"15","author":"S Zecchini","year":"2019","unstructured":"Zecchini S, Giovarelli M, Perrotta C, Morisi F, Touvier T, Di Renzo I, et al. Autophagy controls neonatal myogenesis by regulating the GH-IGF1 system through a NFE2L2- and DDIT3-mediated mechanism. Autophagy. 2019;15:58\u201377.","journal-title":"Autophagy"},{"key":"7595_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13395-016-0115-5","volume":"6","author":"M Thorley","year":"2016","unstructured":"Thorley M, Duguez S, Mazza EMC, Valsoni S, Bigot A, Mamchaoui K, et al. Skeletal muscle characteristics are preserved in hTERT\/cdk4 human myogenic cell lines. Skelet Muscle. 2016;6:43.","journal-title":"Skelet Muscle"},{"key":"7595_CR42","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.1093\/nar\/gkad230","volume":"51","author":"E Mocciaro","year":"2023","unstructured":"Mocciaro E, Giambruno R, Micheloni S, Cernilogar FM, Andolfo A, Consonni C, et al. WDR5 is required for DUX4 expression and its pathological effects in FSHD muscular dystrophy. Nucleic Acids Res. 2023;51:5144\u201361.","journal-title":"Nucleic Acids Res"},{"key":"7595_CR43","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.1016\/j.febslet.2005.08.073","volume":"579","author":"S Neuman","year":"2005","unstructured":"Neuman S, Kovalio M, Yaffe D, Nudel U. The Drosophila homologue of the dystrophin gene - introns containing promoters are the major contributors to the large size of the gene. FEBS Lett. 2005;579:5365\u201371.","journal-title":"FEBS Lett"},{"key":"7595_CR44","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.freeradbiomed.2024.09.037","volume":"225","author":"D Cervia","year":"2024","unstructured":"Cervia D, Zecchini S, Pincigher L, Roux-Biejat P, Zalambani C, Catalani E, et al. Oral administration of plumbagin is beneficial in in vivo models of Duchenne muscular dystrophy through control of redox signaling. Free Radic Biol Med. 2024;225:193\u2013207.","journal-title":"Free Radic Biol Med"},{"key":"7595_CR45","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/sj.emboj.7601503","volume":"26","author":"HR Shcherbata","year":"2007","unstructured":"Shcherbata HR, Yatsenko AS, Patterson L, Sood VD, Nudel U, Yaffe D, et al. Dissecting muscle and neuronal disorders in a Drosophila model of muscular dystrophy. EMBO J. 2007;26:481\u201393.","journal-title":"EMBO J"},{"key":"7595_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fcell.2020.00267","volume":"8","author":"Y Yoshimoto","year":"2020","unstructured":"Yoshimoto Y, Ikemoto-Uezumi M, Hitachi K, Fukada SI, Uezumi A. Methods for accurate assessment of myofiber maturity during skeletal muscle regeneration. Front Cell Dev Biol. 2020;8:267.","journal-title":"Front Cell Dev Biol"},{"key":"7595_CR47","doi-asserted-by":"crossref","unstructured":"Giovarelli M, Zecchini S, Martini E, Garre M, Barozzi S, Ripolone M, et al. Drp1 overexpression induces desmin disassembling and drives kinesin-1 activation promoting mitochondrial trafficking in skeletal muscle. Cell Death Differ. 2020;27:2383\u2013401.","DOI":"10.1038\/s41418-020-0510-7"},{"key":"7595_CR48","doi-asserted-by":"publisher","first-page":"e202000646","DOI":"10.26508\/lsa.202000660","volume":"3","author":"A Reggio","year":"2020","unstructured":"Reggio A, Rosina M, Krahmer N, Palma A, Petrilli LL, Maiolatesi G. et al. Metabolic reprogramming of fibro\/adipogenic progenitors facilitates muscle regeneration. Life Sci. Alliance. 2020;3:e202000646","journal-title":"Life Sci. Alliance"},{"key":"7595_CR49","doi-asserted-by":"publisher","first-page":"859313","DOI":"10.3389\/fnagi.2022.859313","volume":"14","author":"D Liang","year":"2022","unstructured":"Liang D, Chen C, Huang S, Liu S, Fu L, Niu Y. Alterations of Lysine Acetylation profile in murine skeletal muscles upon exercise. Front Aging Neurosci. 2022;14:859313.","journal-title":"Front Aging Neurosci"},{"key":"7595_CR50","doi-asserted-by":"publisher","first-page":"e115763","DOI":"10.1371\/journal.pone.0115763","volume":"9","author":"E Rybalka","year":"2014","unstructured":"Rybalka E, Timpani CA, Cooke MB, Williams AD, Hayes A. Defects in mitochondrial ATP synthesis in dystrophin-deficient mdx skeletal muscles may be caused by complex I insufficiency. PLoS ONE. 2014;9:e115763.","journal-title":"PLoS ONE"},{"key":"7595_CR51","doi-asserted-by":"crossref","unstructured":"Meyer P, Notarnicola C, Meli AC, Matecki S, Hugon G, Salvador J, et al. Skeletal Ryanodine receptors are involved in impaired myogenic differentiation in duchenne muscular dystrophy patients. Int J Mol Sci. 2021;22:12985.","DOI":"10.3390\/ijms222312985"},{"key":"7595_CR52","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.stem.2014.12.004","volume":"16","author":"JG Ryall","year":"2015","unstructured":"Ryall JG, Dell\u2019Orso S, Derfoul A, Juan A, Zare H, Feng X, et al. The NAD(+)-dependent SIRT1 deacetylase translates a metabolic switch into regulatory epigenetics in skeletal muscle stem cells. Cell Stem Cell. 2015;16:171\u201383.","journal-title":"Cell Stem Cell"},{"key":"7595_CR53","doi-asserted-by":"crossref","unstructured":"Careccia G, Mangiavini L, Cirillo F. Regulation of satellite cells functions during skeletal muscle regeneration: a critical step in physiological and pathological conditions. Int J Mol Sci. 2023;25:512.","DOI":"10.3390\/ijms25010512"},{"key":"7595_CR54","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.semcdb.2017.11.010","volume":"72","author":"JM Hernandez-Hernandez","year":"2017","unstructured":"Hernandez-Hernandez JM, Garcia-Gonzalez EG, Brun CE, Rudnicki MA. The myogenic regulatory factors, determinants of muscle development, cell identity and regeneration. Semin Cell Dev Biol. 2017;72:10\u20138.","journal-title":"Semin Cell Dev Biol"},{"key":"7595_CR55","doi-asserted-by":"publisher","first-page":"e0218329","DOI":"10.1371\/journal.pone.0218329","volume":"14","author":"D Fujiwara","year":"2019","unstructured":"Fujiwara D, Iwahara N, Sebori R, Hosoda R, Shimohama S, Kuno A, et al. SIRT1 deficiency interferes with membrane resealing after cell membrane injury. PLoS ONE. 2019;14:e0218329.","journal-title":"PLoS ONE"},{"key":"7595_CR56","doi-asserted-by":"publisher","first-page":"e1004490","DOI":"10.1371\/journal.pgen.1004490","volume":"10","author":"A Chalkiadaki","year":"2014","unstructured":"Chalkiadaki A, Igarashi M, Nasamu AS, Knezevic J, Guarente L. Muscle-specific SIRT1 gain-of-function increases slow-twitch fibers and ameliorates pathophysiology in a mouse model of duchenne muscular dystrophy. PLoS Genet. 2014;10:e1004490.","journal-title":"PLoS Genet"},{"key":"7595_CR57","first-page":"dmm049930","volume":"16","author":"E Domi","year":"2023","unstructured":"Domi E, Hoxha M, Prendi E, Zappacosta B. A systematic review on the role of SIRT1 in Duchenne muscular dystrophy. Cells. 2023;16:dmm049930.","journal-title":"Cells"},{"key":"7595_CR58","doi-asserted-by":"publisher","first-page":"C66","DOI":"10.1152\/ajpcell.00357.2013","volume":"307","author":"V Ljubicic","year":"2014","unstructured":"Ljubicic V, Burt M, Lunde JA, Jasmin BJ. Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1alpha axis. Am J Physiol Cell Physiol. 2014;307:C66\u201382.","journal-title":"Am J Physiol Cell Physiol"},{"key":"7595_CR59","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.clnu.2012.06.003","volume":"32","author":"BS Gordon","year":"2013","unstructured":"Gordon BS, Delgado Diaz DC, Kostek MC. Resveratrol decreases inflammation and increases utrophin gene expression in the mdx mouse model of Duchenne muscular dystrophy. Clinical Nutr. 2013;32:104\u201311.","journal-title":"Clinical Nutr"},{"key":"7595_CR60","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.phrs.2016.02.016","volume":"106","author":"RF Capogrosso","year":"2016","unstructured":"Capogrosso RF, Cozzoli A, Mantuano P, Camerino GM, Massari AM, Sblendorio VT, et al. Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of duchenne muscular dystrophy: a comparison with the gold standard, alpha-methyl prednisolone. Pharmacol Res. 2016;106:101\u201313.","journal-title":"Pharmacol Res"},{"key":"7595_CR61","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1139\/cjpp-2013-0350","volume":"92","author":"BS Gordon","year":"2014","unstructured":"Gordon BS, Delgado-Diaz DC, Carson J, Fayad R, Wilson LB, Kostek MC. Resveratrol improves muscle function but not oxidative capacity in young mdx mice. Can J Physiol Pharm. 2014;92:243\u201351.","journal-title":"Can J Physiol Pharm"},{"key":"7595_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/srep38186","volume":"6","author":"X Hou","year":"2016","unstructured":"Hou X, Rooklin D, Fang H, Zhang Y. Resveratrol serves as a protein-substrate interaction stabilizer in human SIRT1 activation. Scientific Rep. 2016;6. 38186.","journal-title":"Scientific Rep"},{"key":"7595_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.752117","volume":"12","author":"AM Curry","year":"2021","unstructured":"Curry AM, White DS, Donu D, Cen Y. Human Sirtuin Regulators: the \u201cSuccess\u201d Stories. Front Physiol. 2021;12. 752117.","journal-title":"Front Physiol"},{"key":"7595_CR64","doi-asserted-by":"crossref","unstructured":"Springer M, Moco S. Resveratrol and its human metabolites-effects on metabolic health and obesity. Nutrients. 2019;11:143.","DOI":"10.3390\/nu11010143"},{"key":"7595_CR65","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1042\/BJ20091857","volume":"429","author":"B Calamini","year":"2010","unstructured":"Calamini B, Ratia K, Malkowski MG, Cuendet M, Pezzuto JM, Santarsiero BD, et al. Pleiotropic mechanisms facilitated by resveratrol and its metabolites. Biochem J. 2010;429:273\u201382.","journal-title":"Biochem J"},{"key":"7595_CR66","doi-asserted-by":"publisher","first-page":"e51395","DOI":"10.1371\/journal.pone.0051395","volume":"7","author":"V Libri","year":"2012","unstructured":"Libri V, Brown AP, Gambarota G, Haddad J, Shields GS, Dawes H, et al. A pilot randomized, placebo controlled, double blind phase I trial of the novel SIRT1 activator SRT2104 in elderly volunteers. PLoS ONE. 2012;7:e51395.","journal-title":"PLoS ONE"},{"key":"7595_CR67","first-page":"e000647","volume":"4","author":"RM Noh","year":"2017","unstructured":"Noh RM, Venkatasubramanian S, Daga S, Langrish J, Mills NL, Lang NN, et al. Cardiometabolic effects of a novel SIRT1 activator, SRT2104, in people with type 2 diabetes mellitus. Open Heart. 2017;4:e000647.","journal-title":"Open Heart"},{"key":"7595_CR68","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/bcp.12327","volume":"78","author":"A Baksi","year":"2014","unstructured":"Baksi A, Kraydashenko O, Zalevkaya A, Stets R, Elliott P, Haddad J, et al. A phase II, randomized, placebo-controlled, double-blind, multi-dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes. British J Clin Pharmacol. 2014;78:69\u201377.","journal-title":"British J Clin Pharmacol"},{"key":"7595_CR69","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.4103\/1673-5374.313051","volume":"16","author":"H Yang","year":"2021","unstructured":"Yang H, Tang L, Qu Z, Lei SH, Li W, Wang YH. Hippocampal insulin resistance and the Sirtuin 1 signaling pathway in diabetes-induced cognitive dysfunction. Neural Regener Res. 2021;16:2465\u201374.","journal-title":"Neural Regener Res"},{"key":"7595_CR70","doi-asserted-by":"publisher","first-page":"10135","DOI":"10.1074\/jbc.M710277200","volume":"283","author":"MP Gupta","year":"2008","unstructured":"Gupta MP, Samant SA, Smith SH, Shroff SG. HDAC4 and PCAF bind to cardiac sarcomeres and play a role in regulating myofilament contractile activity. J Biol Chem. 2008;283:10135\u201346.","journal-title":"J Biol Chem"},{"key":"7595_CR71","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10974-021-09596-9","volume":"42","author":"B Russell","year":"2021","unstructured":"Russell B, Solis C. Mechanosignaling pathways alter muscle structure and function by post-translational modification of existing sarcomeric proteins to optimize energy usage. J Muscle Res Cell Motil. 2021;42:367\u201380.","journal-title":"J Muscle Res Cell Motil"},{"key":"7595_CR72","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1126\/science.1179687","volume":"327","author":"Q Wang","year":"2010","unstructured":"Wang Q, Zhang Y, Yang C, Xiong H, Lin Y, Yao J, et al. Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science. 2010;327:1004\u20137.","journal-title":"Science"},{"key":"7595_CR73","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.bbapap.2019.06.003","volume":"1867","author":"ZH Zhang","year":"2019","unstructured":"Zhang ZH, Zhang H, Wang YR, Liu XL, Huang H, Xu XH. SIRT 1 binding with PKM and NSE and modulate their acetylation and activities. Biochim et Biophys Acta Proteins Proteom. 2019;1867:794\u2013801.","journal-title":"Biochim et Biophys Acta Proteins Proteom"},{"key":"7595_CR74","doi-asserted-by":"crossref","unstructured":"Walker MA, Chavez J, Villet O, Tang X, Keller A, Bruce JE, et al. Acetylation of muscle creatine kinase negatively impacts high-energy phosphotransfer in heart failure. JCI insight. 2021;6:e144301.","DOI":"10.1172\/jci.insight.144301"},{"key":"7595_CR75","doi-asserted-by":"crossref","unstructured":"Boccanegra B, Mantuano P, Conte E, Cerchiara AG, Tulimiero L, Quarta R, et al. LKB1 signaling is altered in skeletal muscle of a Duchenne muscular dystrophy mouse model. Dis Models Mech. 2023;16.","DOI":"10.1242\/dmm.049930"},{"key":"7595_CR76","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1016\/j.celrep.2016.11.044","volume":"17","author":"S Pambianco","year":"2016","unstructured":"Pambianco S, Giovarelli M, Perrotta C, Zecchini S, Cervia D, Di Renzo I, et al. Reversal of defective mitochondrial biogenesis in limb-girdle muscular dystrophy 2D by independent modulation of histone and PGC-1alpha acetylation. Cell Rep. 2016;17:3010\u201323.","journal-title":"Cell Rep"},{"key":"7595_CR77","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.cmet.2008.08.017","volume":"8","author":"JN Feige","year":"2008","unstructured":"Feige JN, Lagouge M, Canto C, Strehle A, Houten SM, Milne JC, et al. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab. 2008;8:347\u201358.","journal-title":"Cell Metab"},{"key":"7595_CR78","doi-asserted-by":"publisher","first-page":"102040","DOI":"10.1016\/j.redox.2021.102040","volume":"45","author":"E Panza","year":"2021","unstructured":"Panza E, Vellecco V, Iannotti FA, Paris D, Manzo OL, Smimmo M, et al. Duchenne\u2019s muscular dystrophy involves a defective transsulfuration pathway activity. Redox Biol. 2021;45:102040.","journal-title":"Redox Biol"},{"key":"7595_CR79","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s00018-022-04636-0","volume":"79","author":"K Kazirod","year":"2022","unstructured":"Kazirod K, Myszka M, Dulak J, Loboda A. Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases. Cell Mol Life Sci. 2022;79:608.","journal-title":"Cell Mol Life Sci"},{"key":"7595_CR80","doi-asserted-by":"crossref","unstructured":"Saclier M, Ben Larbi S, My Ly H, Moulin E, Mounier R, Chazaud B, et al. Interplay between myofibers and pro-inflammatory macrophages controls muscle damage in mdx mice. J Cell Sci. 2021;134:jcs258429.","DOI":"10.1242\/jcs.258429"},{"key":"7595_CR81","doi-asserted-by":"crossref","unstructured":"Ellwood RA, Hewitt JE, Torregrossa R, Philp AM, Hardee JP, Hughes S, et al. Mitochondrial hydrogen sulfide supplementation improves health in the C. elegans Duchenne muscular dystrophy model. Proc Natl Acad Sci USA. 2021;118:e2018342118.","DOI":"10.1073\/pnas.2018342118"},{"key":"7595_CR82","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.mehy.2015.08.015","volume":"85","author":"CA Timpani","year":"2015","unstructured":"Timpani CA, Hayes A, Rybalka E. Revisiting the dystrophin-ATP connection: how half a century of research still implicates mitochondrial dysfunction in Duchenne Muscular Dystrophy aetiology. Med Hypotheses. 2015;85:1021\u201333.","journal-title":"Med Hypotheses"},{"key":"7595_CR83","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bcp.2018.04.022","volume":"154","author":"P Mantuano","year":"2018","unstructured":"Mantuano P, Sanarica F, Conte E, Morgese MG, Capogrosso RF, Cozzoli A, et al. Effect of a long-term treatment with metformin in dystrophic mdx mice: a reconsideration of its potential clinical interest in Duchenne muscular dystrophy. Biochem Pharm. 2018;154:89\u2013103.","journal-title":"Biochem Pharm"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07595-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07595-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07595-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:49:27Z","timestamp":1744202967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07595-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7595"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07595-z","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures of animal experiments comply with ethical standards and were approved by the Italian Ministry of Health (approval no. 761\/2022-PR). The two pediatric patient-derived immortalized cell lines were granted by biobank MyoLine and used according to the MTA with Prof. Mouly, director of MyoLine biobank in the frame of the agreement with Professor Ornella Cappellari and Professor Matteo Giovarelli respectively at the University of Bari and Milan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"259"}}